Factors of parental COVID-19 vaccine hesitancy: A cross sectional study in Japan.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 01 11 2021
accepted: 26 11 2021
entrez: 17 12 2021
pubmed: 18 12 2021
medline: 11 1 2022
Statut: epublish

Résumé

The eligibility of COVID-19 vaccines has been expanded to children aged 12 and above in several countries including Japan, and there is a plan to further lower the age. This study aimed to assess factors related to parental COVID-19 vaccine hesitancy. A nationwide internet-based cross-sectional study was conducted between May 25 and June 3, 2021 in Japan. The target population was parents of children aged 3-14 years who resided in Japan, and agreed to answer the online questionnaire. Parental COVID-19 vaccine hesitancy (their intention to vaccinate their child) and related factors were analyzed using logistic regression models. Interaction effects of gender of parents and their level of social relationship satisfaction related to parental vaccine hesitancy was tested using log likelihood ratio test (LRT). Social media as the most trusted information source increased parental vaccine hesitancy compared to those who trusted official information (Adjusted Odds Ratio: aOR 2.80, 95% CI 1.53-5.12). Being a mother and low perceived risk of infection also increased parental vaccine hesitancy compared to father (aOR 2.43, 95% CI 1.57-3.74) and those with higher perceived risk of infection (aOR 1.55, 95% CI 1.04-2.32) respectively. People with lower satisfaction to social relationships tended to be more hesitant to vaccinate their child among mothers in contrast to fathers who showed constant intention to vaccinate their child regardless of the level of satisfaction to social relationship (LRT p = 0.021). Our findings suggest that dissemination of targeted information about COVID-19 vaccine by considering means of communication, gender and people who are isolated during measures of social distancing may help to increase parental vaccine acceptance.

Identifiants

pubmed: 34919580
doi: 10.1371/journal.pone.0261121
pii: PONE-D-21-34773
pmc: PMC8683027
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0261121

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Anxiety Disord. 2019 Mar;62:45-52
pubmed: 30529799
Cyberpsychol Behav Soc Netw. 2020 Feb;23(2):126-133
pubmed: 32031898
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Int J Methods Psychiatr Res. 2008;17(3):152-8
pubmed: 18763695
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Vaccines (Basel). 2021 Jun 03;9(6):
pubmed: 34204971
Vaccines (Basel). 2021 Jan 14;9(1):
pubmed: 33466675
Front Public Health. 2021 Jul 01;9:700213
pubmed: 34277557
Psychiatry Res. 2020 Feb;284:112686
pubmed: 31757638
BMC Psychiatry. 2017 Oct 10;17(1):341
pubmed: 29017482
Psychol Med. 2002 Aug;32(6):959-76
pubmed: 12214795
Pediatr Infect Dis J. 2021 Apr 1;40(4):e134-e136
pubmed: 33410650
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
Transl Pediatr. 2021 Jan;10(1):121-135
pubmed: 33633944
Biochem Res Int. 2021 Jul 15;2021:5596727
pubmed: 34336288
Vaccines (Basel). 2021 Apr 10;9(4):
pubmed: 33920109
PLoS One. 2017 Mar 1;12(3):e0172310
pubmed: 28249006
Lancet Reg Health West Pac. 2021 Sep;14:100223
pubmed: 34368797
Vaccines (Basel). 2021 Mar 03;9(3):
pubmed: 33802285
Health Promot Int. 2021 Jul 09;:
pubmed: 34244738
Int J Environ Res Public Health. 2021 May 02;18(9):
pubmed: 34063327
Int J Methods Psychiatr Res. 2012 Jun;21(2):88-97
pubmed: 22351472
PLoS One. 2021 Mar 3;16(3):e0247642
pubmed: 33657152
Hum Vaccin Immunother. 2021 Aug 3;:1-6
pubmed: 34344258
Int J Methods Psychiatr Res. 2010 Jun;19 Suppl 1:4-22
pubmed: 20527002
Vaccines (Basel). 2021 Jun 17;9(6):
pubmed: 34204465

Auteurs

Sayaka Horiuchi (S)

Center for Birth Cohort Studies, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Haruka Sakamoto (H)

Department of Global Health Policy, University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Sarah K Abe (SK)

Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.

Ryoji Shinohara (R)

Center for Birth Cohort Studies, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Megumi Kushima (M)

Center for Birth Cohort Studies, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Sanae Otawa (S)

Center for Birth Cohort Studies, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Hideki Yui (H)

Department of Health Sciences, School of Medicine, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Yuka Akiyama (Y)

Department of Health Sciences, School of Medicine, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Tadao Ooka (T)

Department of Health Sciences, School of Medicine, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Reiji Kojima (R)

Department of Health Sciences, School of Medicine, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Hiroshi Yokomichi (H)

Department of Health Sciences, School of Medicine, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Kunio Miyake (K)

Department of Health Sciences, School of Medicine, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Takashi Mizutani (T)

Minami Nagata Clinic, Yokohama, Japan.

Zentaro Yamagata (Z)

Department of Health Sciences, School of Medicine, University of Yamanashi, Chuo-shi, Yamanashi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH